MARLBOROUGH, Mass., and YOKNEAM ILLIT, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
HUDSON, Mass. and YOKNEAM ILLIT, Israel, May 11, 2026 (GLOBE NEWSWIRE)-- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a diversified biomedical innovation company with a portfolio of ...
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform ...
Lifeward Ltd. (NASDAQ:LFWD) stock is trading higher on Thursday after the company announced that its ReWalk 7 received 510(k) clearance from the Food and Drug Administration (FDA). What To Know: The ...
Lifeward (NASDAQ:LFWD) is preparing to release its quarterly earnings on Friday, 2025-11-14. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...
Up to $47 million strategic investment from Oramed and another investor is intended to provide Lifeward cash runway to profitability and diversify its portfolio across MedTech and BioTech Lifeward ...
Earnings per share (non-GAAP) and revenue (GAAP) for Q2 2025 missed analyst estimates, with revenue (GAAP) down 15% year over year. Gross margin (GAAP) increased in Q2 2025 compared to the prior year, ...
HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 25, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform ...
Lifeward (LFWD) has entered into a definitive agreement for the issuance and sale of an aggregate of 1,818,183 of the Company’s ordinary shares at a purchase price of $2.75 per share in a registered ...
After nearly three years as CFO of Lifeward, Michael Lawless will retire from his role at the Marlborough-based mobility device manufacturer in late June. Effective June 27, Lawless will resign from ...
Transaction Will Transfer Oramed's Oral Drug Delivery Platform (POD™ Technology) to Lifeward and Positions Oramed as a Significant Shareholder Oramed will transfer POD™ platform to Lifeward while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results